Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-005673
Filing Date
2015-01-22
Accepted
2015-01-22 08:35:34
Documents
1
Period of Report
2015-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4080
  Complete submission text file 0001209191-15-005673.txt   5477
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Renz Justin A (Reporting) CIK: 0001466562 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 15540224

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations